Quantcast

Latest Monoclonal antibodies Stories

2014-05-02 23:00:27

The biosimilar products market is segmented into recombinant non-glycosylated proteins, recombinant glycosylated proteins, and recombinant peptides (http://www.marketsandmarkets.com/Market-Reports/biosimilars-40.html). (PRWEB) May 03, 2014 Biosimilars Market Product [Recombinant Non-Glycosylated Proteins (Insulin, Filgrastim, Somatropin), Glycosylated (Monoclonal Antibodies, Erythropoietin), Peptides (Glucagon, Calcitonin)] & Application (Oncology, Blood Disorders) - Global Forecast...

2014-05-01 12:28:46

Reduction in Exacerbations Remains the Top Driver of Physician Prescribing Choice in Moderate to Severe Asthma, According to Findings from Decision Resources Group BURLINGTON, Mass., May 1, 2014 /PRNewswire/ -- Decision Resources Group finds that 90 percent of surveyed U.S. payers indicated a willingness to pay a premium-price for a novel therapy with substantially greater improvements in reducing exacerbations than Genentech/Novartis's Xolair in the treatment of severe asthma. Surveyed U.S....

2014-04-30 23:13:36

Protein expression is an essential component of proteomics that plays an important role in research by allowing the expression of genetically engineered recombinant proteins in various host cells. http://www.marketsandmarkets.com/Market-Reports/protein-expression-market-180323924.html (PRWEB) April 30, 2014 The “Protein Expression Market by Expression Systems (Mammalian, Prokaryotic, Baculovirus, Yeast), by Products (Expression Vector, Service, Reagent), by Application (Industrial,...

2014-04-30 10:21:24

May provide therapeutic target for treating inflammatory bowel disease and preventing colitis-associated colorectal cancer, according to new research published in the American Journal of Pathology The adhesion molecule CD146 plays a vital role in inflammation and offers a promising therapeutic target for treating inflammatory bowel disease (IBD) as well as preventing colitis-associated colorectal cancer, say scientists. Targeting CD146 with anti-CD146 antibody AA98, especially in...

2014-04-30 08:33:09

Proprietary "Smart Antibodies" Allow for Selective Activation in Cancerous Tissues SAN DIEGO, April 30, 2014 /PRNewswire/ -- BioAtla, a global biotechnology company focused on the development of differentiated biological therapeutics, today announced that the United States Patent and Trademark Office (USPTO) has issued to BioAtla U.S. Patent No. 8,709,755, its first patent directed to methods of generating conditionally active antibodies. Conditionally active antibodies are...

2014-04-29 08:35:33

MONROVIA, Calif., April 29, 2014 /PRNewswire/ -- Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases, and cancer, today announced that Bassil Dahiyat, Ph.D., president and chief executive officer, will present at the Deutsche Bank 39th Annual Health Care Conference on Wednesday, May 7, 2014 at 4:50 p.m. EDT in Boston, MA. A live audio webcast of the...

2014-04-29 08:35:02

MUMBAI, April 29, 2014 /PRNewswire/ -- SOURCE Glenmark Pharmaceuticals

2014-04-28 12:27:09

Rheumatologists Cite Improved Health-Related Quality of Life, Improved Effect in Disease Activity among Unmet Needs, According to Findings from Decision Resources Group BURLINGTON, Mass., April 28, 2014 /PRNewswire/ -- Decision Resources Group finds that surveyed U.S. and EU5 rheumatologists agree that new therapies for the treatment of moderate to severe systemic lupus erythematosus (SLE) that offer improved effect on disease activity and renal organ domain scores over current therapies...

2014-04-23 16:23:51

DUBLIN, April 23, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/cqslzn/chromatography) has announced the addition of the "Chromatography Resin Market by Application, Techniques & Type - Trends & Forecast to 2018" [http://www.researchandmarkets.com/research/cqslzn/chromatography ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Ever increasing application in monoclonal...

2014-04-23 08:31:22

The Department of Defense's WRAIR will study Lpath's anti-LPA antibody in the blast injury model of TBI SAN DIEGO, April 23, 2014 /PRNewswire/ -- Lpath, Inc. (NASDAQ: LPTN), the industry leader in bioactive lipid-targeted therapeutics, and scientists from the Center for Military Psychiatry and Neuroscience, Walter Reed Army Institute of Research (WRAIR), have initiated a study that is the focus of a collaborative research agreement. The collaboration involves the use of...


Word of the Day
lambent
  • Licking.
  • Hence Running along or over a surface, as if in the act of licking; flowing over or along; lapping or bathing; softly bright; gleaming.
This word comes the Latin 'lambere,' to lick.
Related